The latest from Group 31

Customer relationship management (CRM) systems can be powerful tools when used strategically. Recently, Group 31 Communications CEO Crystal Weber was invited to present a webinar for NCBiotech on optimizing CRM strategies for biotech and life sciences companies. While preparing, she realized something: if you approach your CRM like a science experiment, it can completely change how you engage with investors, key opinion leaders (KOLs), and partners.

Group 31 CEO Crystal Weber recently appeared on the podcast The Factor, by Kymanox, where she shared insights into how expert guidance can help biotech and pharma companies navigate regulations while delivering compelling marketing messages. Now we’re sharing 5 key takeaways from that interview.

Crystal Weber, of Group 31 in Raleigh, is being recognized for her ability to innovate and inspire. MM+M has announced its 2024 Women of Distinction and Women to Watch honorees. Now in their ninth year, the MM+M Women of Distinction and Women to Watch programs celebrate healthcare marketing executives who have significantly impacted their organizations — and the industry writ large — during the past year.